Bumper Offer - Urjas oil Just @ Rs. 1
Jubira 20 Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of High Cholesterol. Secondary and off-label uses of Jubira 20 Tablet have also been mentioned below.
The optimal dosage of Jubira 20 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Jubira 20 Tablet side effects, there are can be others also. These have been listed below. Such side effects of Jubira 20 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Jubira 20 Tablet's effect during pregnancy is Severe and Mild while nursing. Further, the section on Jubira 20 Tablet related warnings talks about Jubira 20 Tablet's effects on the liver, heart and kidney.
Jubira 20 Tablet is contraindicated in people with pre-existing medical conditions like Kidney Disease, Hypothyroidism, Drug Allergy as it can result in adverse effects. The section on Jubira 20 Tablet contraindications lists all such conditions.
Drug interactions for Jubira 20 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Jubira 20 Tablet is safe while driving, and is is addictive in nature.
Jubira 20 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Jubira 20 Tablet is used -
Severe
Moderate
Mild
Is the use of Jubira 20 Tablet safe for pregnant women?
Jubira should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Jubira 20 Tablet safe during breastfeeding?
Jubira may have very limited harmful effects for breastfeeding women.
What is the effect of Jubira 20 Tablet on the Kidneys?
Kidney can be affected by Jubira. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Jubira 20 Tablet on the Liver?
Jubira may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Jubira 20 Tablet on the Heart?
Jubira has very mild side effects on the heart.
Jubira 20 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Jubira 20 Tablet unless your doctor advises you to do so -
Is this Jubira 20 Tablet habit forming or addictive?
Forming a habit of Jubira 20 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Jubira 20 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Jubira 20 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Jubira 20 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Jubira 20 Tablet
Taking Jubira 20 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Jubira 20 Tablet
Consumption of alcohol and Jubira 20 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
